Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Reexamination Certificate
2011-05-03
2011-05-03
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
C514S478000, C558S001000, C558S233000, C558S234000, C558S241000, C560S027000
Reexamination Certificate
active
07935727
ABSTRACT:
Compounds having a biphenyl group substituted with a phenyl or heteroaromatic group, as shown in Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:
REFERENCES:
patent: 5599952 (1997-02-01), Matsumoto et al.
patent: 6458803 (2002-10-01), Sikorski et al.
patent: 2004/0058903 (2004-03-01), Takasugi et al.
patent: 2004/0082658 (2004-04-01), Harter et al.
patent: 2004/0220231 (2004-11-01), Lee et al.
patent: 2004/0229957 (2004-11-01), Shinkai et al.
patent: WO 2005/100298 (2005-10-01), None
Chen Yi-Heng
Lu Zhijian
Sinclair Peter J.
Daniel Mark R.
McGinnis James L.
Merck Sharp & Dohme Corp.
Pihonak Sarah
Wang Shengjun
LandOfFree
CETP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CETP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CETP inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2673998